Market Currents
Off sharply on Tuesday after filing to sell 7M shares, Alnylam Pharmaceuticals (ALNY +14.7%) is...
-
Wednesday, February 15, 2012, 2:28 PM ETOff sharply on Tuesday after filing to sell 7M shares, Alnylam Pharmaceuticals (ALNY +14.7%) is more than recouping its losses after pricing its offering (increased to 7.5M shares) at $10.75. A high short interest (11.2% of float shorted as of Jan. 31) could be contributing to recent volatility.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
